Submitted:
02 February 2025
Posted:
03 February 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction

2. Graphical Analysis of Global Mortality Based on Our World Data

3. Exact Mathematical Model to Evaluate Results of COVID-19 Vaccination
4. Negative Causal Correlation Between the Intensity of Vaccination and Mortality Rate

5. Methodological Errors of Models Evaluating COVID-19 Vaccination Efficiency
6. Conclusions
References
- Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: A retrospective surveillance study, Meslé, Margaux M IMesle, Margaux MI et al. The Lancet Respiratory Medicine 2024, 12(9), 714–727. [CrossRef]
- Makovec, T.; Šorli, A.S.; Gorjup, R.; Krevel, Z.; Piberl, S. Analysis of COVID-19 Vaccination Effectiveness. J Vaccines Vaccin. 2023, 14, 530. Available online: https://www.walshmedicalmedia.com/open-access/analysis-of-covid19-vaccination-effectiveness.pdf.
- Watson, O.J.; Barnsley, G.; Toor, J.; Hogan, A.B.; Winskill, P.; Ghani, A.C. Global impact of the first year of COVID-19 vaccination: A mathematical modelling study. Lancet Infect Dis. 2022, 22(9), 1293–1302. [Google Scholar] [CrossRef]
- Šorli, S.; Makovec, T.; Krevel, Z.; Gorjup, R. Forgotten “Primum Non Nocere” and increased mortality after COVID-19 vaccination. Qual Prim Care. 2023, 31(6), 56–64. Available online: https://www.primescholars.com/articles/forgotten-primum-non-nocere-and-increased-mortality-after--covid19-vaccination.pdf.
- World Health Organization. 14.9 million excess deaths associated with the COVID-19 pandemic in 2020 and 2021; World Health Organization, 2022. Available online: https://www.who.int/news/item/05-05-2022-14.9-million-excess-deaths-were-associated-with-the-covid-19-pandemic-in-2020-and-2021.
- Kislaya, I.; Machado, A.; Magalhães, S.; Rodrigues, A.P.; Franco, R.; Leite, PP.; Dias, C.M.; Nunes, B. COVID-19 mRNA vaccine effectiveness (second and first booster dose) against hospitalisation and death during Omicron BA.5 circulation: Cohort study based on electronic health records, Portugal, May to July 2022. Euro Surveill. 2022, 27(37), 2200697. [Google Scholar] [CrossRef] [PubMed]
- Wu, N.; Joyal-Desmarais, K.; Ribeiro, P.A.B.; Vieira, A.M.; Stojanovic, J.; Sanuade, C.; Yip, D.; Bacon, S.L. Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: Findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022. Lancet Respir Med. 2023, 11(5), 439–452. [Google Scholar] [CrossRef]
- Savinkina, A.; Bilinski, A.; Fitzpatrick, M.; Paltiel, A.D.; Rizvi, Z.; Salomon, J.; Thornhill, T.; Gonsalves, G. Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: A modelling study. BMJ Open 2022, 12(9), e061752. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).